StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2013, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 21 May 2013 13:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday GeneNews to Present at the Bloom Burton & Co. Healthcare Investor Conference http://www.streetinsider.com/Press+Releases/GeneNews+to+Present+at+the+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/8358699.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/GeneNews+to+Present+at+the+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/8358699.html for the full story. http://www.streetinsider.com/Press+Releases/GeneNews+to+Present+at+the+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/8358699.html Tue, 21 May 2013 13:30:00 -0400 GEN Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case http://www.streetinsider.com/Press+Releases/Genentech+and+Biogen+Idec+Have+Filed+for+a+Re-hearing+of+U.S.+Court+of+Appeals+Decision+in+the+Arzerra+Patent+Infringement+Case/8349697.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Genentech+and+Biogen+Idec+Have+Filed+for+a+Re-hearing+of+U.S.+Court+of+Appeals+Decision+in+the+Arzerra+Patent+Infringement+Case/8349697.html for the full story. http://www.streetinsider.com/Press+Releases/Genentech+and+Biogen+Idec+Have+Filed+for+a+Re-hearing+of+U.S.+Court+of+Appeals+Decision+in+the+Arzerra+Patent+Infringement+Case/8349697.html Fri, 17 May 2013 06:51:00 -0400 A.40151759 GEN GNMSF GNMSY Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case http://www.streetinsider.com/Press+Releases/Genentech+and+Biogen+Idec+Have+Filed+for+a+Re-hearing+of+U.S.+Court+of+Appeals+Decision+in+the+Arzerra+Patent+Infringement+Case/8349697.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Genentech+and+Biogen+Idec+Have+Filed+for+a+Re-hearing+of+U.S.+Court+of+Appeals+Decision+in+the+Arzerra+Patent+Infringement+Case/8349697.html for the full story. http://www.streetinsider.com/Press+Releases/Genentech+and+Biogen+Idec+Have+Filed+for+a+Re-hearing+of+U.S.+Court+of+Appeals+Decision+in+the+Arzerra+Patent+Infringement+Case/8349697.html Fri, 17 May 2013 06:51:00 -0400 A.40151759 GEN GNMSF GNMSY Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case http://www.streetinsider.com/Press+Releases/Genentech+and+Biogen+Idec+Have+Filed+for+a+Re-hearing+of+U.S.+Court+of+Appeals+Decision+in+the+Arzerra+Patent+Infringement+Case/8349697.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Genentech+and+Biogen+Idec+Have+Filed+for+a+Re-hearing+of+U.S.+Court+of+Appeals+Decision+in+the+Arzerra+Patent+Infringement+Case/8349697.html for the full story. http://www.streetinsider.com/Press+Releases/Genentech+and+Biogen+Idec+Have+Filed+for+a+Re-hearing+of+U.S.+Court+of+Appeals+Decision+in+the+Arzerra+Patent+Infringement+Case/8349697.html Fri, 17 May 2013 06:51:00 -0400 A.40151759 GEN GNMSF GNMSY Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case http://www.streetinsider.com/Press+Releases/Genentech+and+Biogen+Idec+Have+Filed+for+a+Re-hearing+of+U.S.+Court+of+Appeals+Decision+in+the+Arzerra+Patent+Infringement+Case/8349697.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Genentech+and+Biogen+Idec+Have+Filed+for+a+Re-hearing+of+U.S.+Court+of+Appeals+Decision+in+the+Arzerra+Patent+Infringement+Case/8349697.html for the full story. http://www.streetinsider.com/Press+Releases/Genentech+and+Biogen+Idec+Have+Filed+for+a+Re-hearing+of+U.S.+Court+of+Appeals+Decision+in+the+Arzerra+Patent+Infringement+Case/8349697.html Fri, 17 May 2013 06:51:00 -0400 A.40151759 GEN GNMSF GNMSY GeneNews Reports Q1 2013 Financial Results http://www.streetinsider.com/Press+Releases/GeneNews+Reports+Q1+2013+Financial+Results/8344145.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/GeneNews+Reports+Q1+2013+Financial+Results/8344145.html for the full story. http://www.streetinsider.com/Press+Releases/GeneNews+Reports+Q1+2013+Financial+Results/8344145.html Wed, 15 May 2013 17:00:00 -0400 GEN Form 10-Q GenOn Energy, Inc. For: Mar 31 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++GenOn+Energy%2C+Inc.++++++++For%3A+Mar+31/8313455.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++GenOn+Energy%2C+Inc.++++++++For%3A+Mar+31/8313455.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++GenOn+Energy%2C+Inc.++++++++For%3A+Mar+31/8313455.html Tue, 07 May 2013 16:04:00 -0400 GEN Genmab Announces Financial Results for the First Quarter of 2013 http://www.streetinsider.com/Press+Releases/Genmab+Announces+Financial+Results+for+the+First+Quarter+of+2013/8312161.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Genmab+Announces+Financial+Results+for+the+First+Quarter+of+2013/8312161.html for the full story. http://www.streetinsider.com/Press+Releases/Genmab+Announces+Financial+Results+for+the+First+Quarter+of+2013/8312161.html Tue, 07 May 2013 11:08:00 -0400 A.13262510 A.26630690 A.40151759 GEN GNMSF GNMSY Genmab Announces Financial Results for the First Quarter of 2013 http://www.streetinsider.com/Press+Releases/Genmab+Announces+Financial+Results+for+the+First+Quarter+of+2013/8312161.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Genmab+Announces+Financial+Results+for+the+First+Quarter+of+2013/8312161.html for the full story. http://www.streetinsider.com/Press+Releases/Genmab+Announces+Financial+Results+for+the+First+Quarter+of+2013/8312161.html Tue, 07 May 2013 11:08:00 -0400 A.13262510 A.26630690 A.40151759 GEN GNMSF GNMSY Genmab Announces Financial Results for the First Quarter of 2013 http://www.streetinsider.com/Press+Releases/Genmab+Announces+Financial+Results+for+the+First+Quarter+of+2013/8312161.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Genmab+Announces+Financial+Results+for+the+First+Quarter+of+2013/8312161.html for the full story. http://www.streetinsider.com/Press+Releases/Genmab+Announces+Financial+Results+for+the+First+Quarter+of+2013/8312161.html Tue, 07 May 2013 11:08:00 -0400 A.13262510 A.26630690 A.40151759 GEN GNMSF GNMSY Genmab Announces Financial Results for the First Quarter of 2013 http://www.streetinsider.com/Press+Releases/Genmab+Announces+Financial+Results+for+the+First+Quarter+of+2013/8312161.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Genmab+Announces+Financial+Results+for+the+First+Quarter+of+2013/8312161.html for the full story. http://www.streetinsider.com/Press+Releases/Genmab+Announces+Financial+Results+for+the+First+Quarter+of+2013/8312161.html Tue, 07 May 2013 11:08:00 -0400 A.13262510 A.26630690 A.40151759 GEN GNMSF GNMSY Genmab Announces Financial Results for the First Quarter of 2013 http://www.streetinsider.com/Press+Releases/Genmab+Announces+Financial+Results+for+the+First+Quarter+of+2013/8312161.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Genmab+Announces+Financial+Results+for+the+First+Quarter+of+2013/8312161.html for the full story. http://www.streetinsider.com/Press+Releases/Genmab+Announces+Financial+Results+for+the+First+Quarter+of+2013/8312161.html Tue, 07 May 2013 11:08:00 -0400 A.13262510 A.26630690 A.40151759 GEN GNMSF GNMSY Genmab Announces Financial Results for the First Quarter of 2013 http://www.streetinsider.com/Press+Releases/Genmab+Announces+Financial+Results+for+the+First+Quarter+of+2013/8312161.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Genmab+Announces+Financial+Results+for+the+First+Quarter+of+2013/8312161.html for the full story. http://www.streetinsider.com/Press+Releases/Genmab+Announces+Financial+Results+for+the+First+Quarter+of+2013/8312161.html Tue, 07 May 2013 11:08:00 -0400 A.13262510 A.26630690 A.40151759 GEN GNMSF GNMSY Genmab Announces Top-Line Phase II Results for Ofatumumab Combined With Bendamustine in Untreated and Relapsed Chronic Lymphocytic Leukemia http://www.streetinsider.com/Press+Releases/Genmab+Announces+Top-Line+Phase+II+Results+for+Ofatumumab+Combined+With+Bendamustine+in+Untreated+and+Relapsed+Chronic+Lymphocytic+Leukemia/8294413.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Genmab+Announces+Top-Line+Phase+II+Results+for+Ofatumumab+Combined+With+Bendamustine+in+Untreated+and+Relapsed+Chronic+Lymphocytic+Leukemia/8294413.html for the full story. http://www.streetinsider.com/Press+Releases/Genmab+Announces+Top-Line+Phase+II+Results+for+Ofatumumab+Combined+With+Bendamustine+in+Untreated+and+Relapsed+Chronic+Lymphocytic+Leukemia/8294413.html Wed, 01 May 2013 12:56:00 -0400 A.16812587 GEN GNMSF GNMSY Genmab Announces Top-Line Phase II Results for Ofatumumab Combined With Bendamustine in Untreated and Relapsed Chronic Lymphocytic Leukemia http://www.streetinsider.com/Press+Releases/Genmab+Announces+Top-Line+Phase+II+Results+for+Ofatumumab+Combined+With+Bendamustine+in+Untreated+and+Relapsed+Chronic+Lymphocytic+Leukemia/8294413.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Genmab+Announces+Top-Line+Phase+II+Results+for+Ofatumumab+Combined+With+Bendamustine+in+Untreated+and+Relapsed+Chronic+Lymphocytic+Leukemia/8294413.html for the full story. http://www.streetinsider.com/Press+Releases/Genmab+Announces+Top-Line+Phase+II+Results+for+Ofatumumab+Combined+With+Bendamustine+in+Untreated+and+Relapsed+Chronic+Lymphocytic+Leukemia/8294413.html Wed, 01 May 2013 12:56:00 -0400 A.16812587 GEN GNMSF GNMSY Genmab Announces Top-Line Phase II Results for Ofatumumab Combined With Bendamustine in Untreated and Relapsed Chronic Lymphocytic Leukemia http://www.streetinsider.com/Press+Releases/Genmab+Announces+Top-Line+Phase+II+Results+for+Ofatumumab+Combined+With+Bendamustine+in+Untreated+and+Relapsed+Chronic+Lymphocytic+Leukemia/8294413.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Genmab+Announces+Top-Line+Phase+II+Results+for+Ofatumumab+Combined+With+Bendamustine+in+Untreated+and+Relapsed+Chronic+Lymphocytic+Leukemia/8294413.html for the full story. http://www.streetinsider.com/Press+Releases/Genmab+Announces+Top-Line+Phase+II+Results+for+Ofatumumab+Combined+With+Bendamustine+in+Untreated+and+Relapsed+Chronic+Lymphocytic+Leukemia/8294413.html Wed, 01 May 2013 12:56:00 -0400 A.16812587 GEN GNMSF GNMSY Genmab Announces Top-Line Phase II Results for Ofatumumab Combined With Bendamustine in Untreated and Relapsed Chronic Lymphocytic Leukemia http://www.streetinsider.com/Press+Releases/Genmab+Announces+Top-Line+Phase+II+Results+for+Ofatumumab+Combined+With+Bendamustine+in+Untreated+and+Relapsed+Chronic+Lymphocytic+Leukemia/8294413.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Genmab+Announces+Top-Line+Phase+II+Results+for+Ofatumumab+Combined+With+Bendamustine+in+Untreated+and+Relapsed+Chronic+Lymphocytic+Leukemia/8294413.html for the full story. http://www.streetinsider.com/Press+Releases/Genmab+Announces+Top-Line+Phase+II+Results+for+Ofatumumab+Combined+With+Bendamustine+in+Untreated+and+Relapsed+Chronic+Lymphocytic+Leukemia/8294413.html Wed, 01 May 2013 12:56:00 -0400 A.16812587 GEN GNMSF GNMSY Daratumumab Receives Breakthrough Therapy Designation From US Food and Drug Administration http://www.streetinsider.com/Press+Releases/Daratumumab+Receives+Breakthrough+Therapy+Designation+From+US+Food+and+Drug+Administration/8294150.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Daratumumab+Receives+Breakthrough+Therapy+Designation+From+US+Food+and+Drug+Administration/8294150.html for the full story. http://www.streetinsider.com/Press+Releases/Daratumumab+Receives+Breakthrough+Therapy+Designation+From+US+Food+and+Drug+Administration/8294150.html Wed, 01 May 2013 11:52:00 -0400 A.13262510 A.26630690 GEN GNMSF GNMSY Daratumumab Receives Breakthrough Therapy Designation From US Food and Drug Administration http://www.streetinsider.com/Press+Releases/Daratumumab+Receives+Breakthrough+Therapy+Designation+From+US+Food+and+Drug+Administration/8294150.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Daratumumab+Receives+Breakthrough+Therapy+Designation+From+US+Food+and+Drug+Administration/8294150.html for the full story. http://www.streetinsider.com/Press+Releases/Daratumumab+Receives+Breakthrough+Therapy+Designation+From+US+Food+and+Drug+Administration/8294150.html Wed, 01 May 2013 11:52:00 -0400 A.13262510 A.26630690 GEN GNMSF GNMSY Daratumumab Receives Breakthrough Therapy Designation From US Food and Drug Administration http://www.streetinsider.com/Press+Releases/Daratumumab+Receives+Breakthrough+Therapy+Designation+From+US+Food+and+Drug+Administration/8294150.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Daratumumab+Receives+Breakthrough+Therapy+Designation+From+US+Food+and+Drug+Administration/8294150.html for the full story. http://www.streetinsider.com/Press+Releases/Daratumumab+Receives+Breakthrough+Therapy+Designation+From+US+Food+and+Drug+Administration/8294150.html Wed, 01 May 2013 11:52:00 -0400 A.13262510 A.26630690 GEN GNMSF GNMSY Daratumumab Receives Breakthrough Therapy Designation From US Food and Drug Administration http://www.streetinsider.com/Press+Releases/Daratumumab+Receives+Breakthrough+Therapy+Designation+From+US+Food+and+Drug+Administration/8294150.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Daratumumab+Receives+Breakthrough+Therapy+Designation+From+US+Food+and+Drug+Administration/8294150.html for the full story. http://www.streetinsider.com/Press+Releases/Daratumumab+Receives+Breakthrough+Therapy+Designation+From+US+Food+and+Drug+Administration/8294150.html Wed, 01 May 2013 11:52:00 -0400 A.13262510 A.26630690 GEN GNMSF GNMSY Daratumumab Receives Breakthrough Therapy Designation From US Food and Drug Administration http://www.streetinsider.com/Press+Releases/Daratumumab+Receives+Breakthrough+Therapy+Designation+From+US+Food+and+Drug+Administration/8294150.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Daratumumab+Receives+Breakthrough+Therapy+Designation+From+US+Food+and+Drug+Administration/8294150.html for the full story. http://www.streetinsider.com/Press+Releases/Daratumumab+Receives+Breakthrough+Therapy+Designation+From+US+Food+and+Drug+Administration/8294150.html Wed, 01 May 2013 11:52:00 -0400 A.13262510 A.26630690 GEN GNMSF GNMSY Arzerra First Quarter 2013 Net Sales Figures http://www.streetinsider.com/Press+Releases/Arzerra+First+Quarter+2013+Net+Sales+Figures/8273576.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Arzerra+First+Quarter+2013+Net+Sales+Figures/8273576.html for the full story. http://www.streetinsider.com/Press+Releases/Arzerra+First+Quarter+2013+Net+Sales+Figures/8273576.html Wed, 24 Apr 2013 07:11:00 -0400 GEN GNMSF GNMSY Arzerra First Quarter 2013 Net Sales Figures http://www.streetinsider.com/Press+Releases/Arzerra+First+Quarter+2013+Net+Sales+Figures/8273576.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Arzerra+First+Quarter+2013+Net+Sales+Figures/8273576.html for the full story. http://www.streetinsider.com/Press+Releases/Arzerra+First+Quarter+2013+Net+Sales+Figures/8273576.html Wed, 24 Apr 2013 07:11:00 -0400 GEN GNMSF GNMSY Arzerra First Quarter 2013 Net Sales Figures http://www.streetinsider.com/Press+Releases/Arzerra+First+Quarter+2013+Net+Sales+Figures/8273576.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Arzerra+First+Quarter+2013+Net+Sales+Figures/8273576.html for the full story. http://www.streetinsider.com/Press+Releases/Arzerra+First+Quarter+2013+Net+Sales+Figures/8273576.html Wed, 24 Apr 2013 07:11:00 -0400 GEN GNMSF GNMSY